Posted in Clinical Data Novo says oral semaglutide works in diabetic kids April 23, 2026 Pharmaphorum Novo Nordisk will file oral formulations of its GLP-1 agonist semaglutide for children and adolescents with type 2 diabetes later this year. Clinical DataMetabolic & GLP-1Read full story